It would be of interest to determine which sites are bound by both PR and EZH2 in normal mammary gland and in breast cancer cells by the use of genome-wide approaches, potentially allowing the identification of target genes repressed by PR in an EZH2-dependent manner. Here, EZH2 is linked to breast cancer.